Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novagali Pharma SA

Division of Santen Pharmaceutical Co. Ltd.
www.novagali.com

Latest From Novagali Pharma SA

Appointments: Piramal Pharma, Oxeia, Artios Eyevensys and Bone Therapeutics

This week's roundup includes a new CEO for Oxeia, in addition to various other high-level appointments by Piramal Pharma Solutions, Bone Therapeutics, Kiadis and biOasis. Artios Pharma also welcomes AstraZeneca's former senior director bioscience, oncology to its team.

Appointments BioPharmaceutical

Financings Of The Fortnight: Idenix To Forge Ahead On HCV Combo After Novartis’ Departure

Plus news on recent financial activity by Mersana Therapeutics, Hyperion Therapeutics, Atterocor and Exelixis.

BioPharmaceutical Business Strategies

Financings Of The Fortnight: Secondary Offerings Up From Pace Set In 2010 And 2011

Plus news on recent financings by Genkyotex, Synageva, Nektar Therapeutics and Edmond de Rothschild Investment Partners.

BioPharmaceutical Business Strategies

EdRIP raising €200M for new life sciences VC fund

Four years after closing the BioDiscovery 3 at €156 million, Edmond de Rothschild Investment Partners is now on the road raising a €200 million fourth fund to invest innovative European life sciences companies. The French venture capitalist started fundraising three weeks ago and is confident that it will be able to complete a first closing at more than €100 million by the end of April or early May.

Metabolic Disorders Gynecology & Urology
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Topical Delivery
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Santen Pharmaceutical Co. Ltd.
  • Senior Management
  • Jerome Martinez, Pres. & CEO
    Jean-Sébastien Garrigue, Dir., Rsearch & Pharma. Dev.
  • Contact Info
  • Novagali Pharma SA
    Phone: (33) 69 87 40 20
    1 rue Pierre Fontaine
    Genavenir IV
    Evry Cedex, 91058
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register